RT @1derfultype: #thread Katarina Braune @friendocrino on #DIYAPS ▶️
Why has the #WeAreNotWaiting movement grown so fast since 2013 with about 8 to 10,000 users worldwide?
Because it has reshaped #T1D self-management improving sleep, #QofL, #TIR, feeling good!
#dedoc°voices #ATTD2021 #diabetes https://t.co/yyT8gQnaql
Nat’s Pancreas 404 💉💉 #COVIDisAirborne on Twitter
“#thread Katarina Braune @friendocrino on #DIYAPS ▶️
Why has the #WeAreNotWaiting movement grown so fast since 2013 with about 8 to 10,000 users worldwide?
Because it has reshaped #T1D self-management improving sleep, #QofL, #TIR, feeling good!
#dedoc°voices #ATTD2021 #diabetes”
RT @uffehs: Presentation on the topic "Social media" by @parthaskar on @ATTDconf "Social media can be a gateway to peer support"
#DOC #SoMe #ATTD2021 https://t.co/sQ4XD2dQeAUffe Søholm on Twitter
“Presentation on the topic "Social media" by @parthaskar on @ATTDconf "Social media can be a gateway to peer support" #DOC #SoMe #ATTD2021”
RT @PracticalDeeb: Day 3 of @ATTDconf
#ATTD2021 kicks off with the ATTD Yearbook 2020, a review of the best academic papers of the last 12 months in Diabetes Technology and Therapeutics.
#dedoc°
https://t.co/M7Jc1Il5y7The Practical Diabetic (Leon Tribe) on Twitter
“Day 3 of @ATTDconf #ATTD2021 kicks off with the ATTD Yearbook 2020, a review of the best academic papers of the last 12 months in Diabetes Technology and Therapeutics. #dedoc°”
RT @drtrangly: I’m so proud of this algorithm we built @myomnipod
#ATTD2021 #omnipod5 https://t.co/j4lJ4kr8PfTrang Ly on Twitter
“I’m so proud of this algorithm we built @myomnipod #ATTD2021 #omnipod5”
RT @nerdabetic: Interesting to hear that @CamAPS_FX app is updated regularly (usually every couple of weeks) with new features based on users feedback. This is a massive advantage of using apps. Snacking meal sounds like a great addition!
#ATTD2021 https://t.co/kXIHLzLPD9Nerdabetic on Twitter
“Interesting to hear that @CamAPS_FX app is updated regularly (usually every couple of weeks) with new features based on users feedback. This is a massive advantage of using apps. Snacking meal sounds like a great addition! #ATTD2021”
RT @Blue_Sugar_Cube: Dr. Steven Edelman says that #HbA1c from the laboratory is the estimated and the one from CGM is the real #A1c! 😮
#dedoc #dedocvoices #ATTD2021 #payitforward https://t.co/74Y6FxOeXM
Weronika Burkot on Twitter
“Dr. Steven Edelman says that #HbA1c from the laboratory is the estimated and the one from CGM is the real #A1c! 😮
#dedoc #dedocvoices #ATTD2021 #payitforward”
RT @othmar_moser:
#ATTD2021 Recent meta-analysis led by Dr. @Max_Eckstein @unibt shows that fully closed loop is superior (TIR) to standard of care for EXERCISE – great effects especially in children and adolescents with T1D @MCRiddell1 @DovcK @TBattelino @nerdabetic
https://t.co/cibJMaEC4v
Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis
The aim of this systematic review and meta-analysis was to compare time in range (TIR) (70–180 mg/dL (3.9–10.0 mmol/L)) between fully closed-loop systems (CLS) and standard of care (including hybrid systems) during physical exercise in people with type 1 diabetes (T1D). A systematic literature search was conducted in EMBASE, PubMed, Cochrane Central Register of Controlled Trials, and ISI Web of Science from January 1950 until January 2020. Randomized controlled trials including studies with different CLS were compared against standard of care in people with T1D. The meta-analysis was performed using the random effects model and restricted maximum likelihood estimation method. Six randomized controlled trials involving 153 participants with T1D of all age groups were included. Due to crossover test designs, studies were included repeatedly (a–d) if CLS or physical exercise interventions were different. Applying this methodology increased the comparisons to a total number of 266 participants. TIR was higher with an absolute mean difference (AMD) of 6.18%, 95% CI: 1.99 to 10.38% in favor of CLS. In a subgroup analysis, the AMD was 9.46%, 95% CI: 2.48% to 16.45% in children and adolescents while the AMD for adults was 1.07% 95% CI: −0.81% to 2.96% in favor of CLS. In this systematic review and meta-analysis CLS moderately improved TIR in comparison to standard of care during physical exercise in people with T1D. This effect was particularly pronounced for children and adolescents showing that the use of CLS improved TIR significantly compared to standard of care.
RT @drfrasergibb:
https://t.co/gSrA21GUlv Incremental benefit of rtCGM over iscCGM (flash) in people with T1 diabetes - presented at
#ATTD2021RT @nerdabetic: No calibration CGM from Medtronic has just been CE approved- Guardian 4. It is a 7-day sensor that connects with 780G, InPen smart pen or standalone CGM app.
#ATTD2021 Find out more in my new video about Medtronics new CGM:
https://t.co/nKSdzCvAdz https://t.co/kiG5c4r5jv
Medtronic's new NO calibration CGM approved- Guardian 4
Medtronics newest CGM is here and it has just been CE marked for Europe and Middle Eastern countries. Guardian 4 is Medtronics first calibration-free CGM (fi...
RT @ATTDconf: A recap of the major scientific data presentations on @Medtronic innovation that took place at
#ATTD2020.
#ATTD2021 #diabetes #ClosedLoop https://t.co/C7f4JYMoYWAdvanced Hybrid Closed Loop System Early Feasibility Data on Patients Undergoing Unannounced Meal Challenges Shows Promising Results
Positive Data on Many Medtronic Innovations Presented at ATTD: Extended Wear Infusion Set Designed to Last Twice as Long, MiniMed™ 670G System Real-Life Performance in Europe,...
Birdfly